Mimopezil
- Generic Name
- Mimopezil
- Drug Type
- Small Molecule
- Chemical Formula
- C23H23ClN2O3
- CAS Number
- 180694-97-7
- Unique Ingredient Identifier
- 4MU6P880QL
- Background
Mimopezil is an acetylcholinesterase (AChE) inhibitor that has demonstrated potential use in the treatment of Alzheimer's disease. Mimopezil is a pro-drug that is rapidly absorbed and converted into huperzine A.
- Indication
Investigated for use/treatment in alzheimer's disease.
Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Debiopharm International SA
- Target Recruit Count
- 228
- Registration Number
- NCT00423228
- Locations
- 🇦🇺
Central Coast Neuroscience Research, East Gosford, New South Wales, Australia
🇦🇺Hornsby-Kuring-gai Health Service, Hornsby, New South Wales, Australia
🇦🇺The Prince Charles Hospital, Chermside, Queensland, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath